Losmapimod oral tablet
FIS-002-2019
Phase 2 small_molecule completed
Quick answer
Losmapimod oral tablet for Facioscapulohumeral Muscular Dystrophy (FSHD) is a Phase 2 program (small_molecule) at Fulcrum Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Fulcrum Therapeutics
- Indication
- Facioscapulohumeral Muscular Dystrophy (FSHD)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed